Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors

Fig. 4

Factors selection and nomogram construction based on peripheral blood immune indices of PFS. a The LASSO coefficient profiles of the candidate variables; b the optimal tuning λ in the LASSO analysis selected with tenfold cross-validation via minimum criteria; c forest plot of multivariate analysis independent prognostic analysis of PFS. d “NKT-B” nomogram (based on change-CD3+CD56+CD16+NKT-like cells and change-B cells) was established to assess 1-year PFS of aNSCLC patients receiving ICIs; e the ROC curve of the nomogram for 1-year PFS; f calibration curves of the nomogram for 1-year PFS; g decision curve analysis of the nomogram for 1-year PFS; h Kaplan–Meier curves depicting PFS according to risk levels (cut-point value: − 4.1868)

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us